Four vaccines are most commonly recommended for adults heading into respiratory virus season: flu, RSV, pneumococcal, and shingles. None of the four applies to every adult over 60, and the eligibility rules differ enough that assuming otherwise leads people to either skip a shot they need or ask for one they do not.
The complication this year is that the federal reference document has not been refreshed. The CDC's adult immunization schedule still carries a July 2025 review date and is labeled the 2025 schedule because the Advisory Committee on Immunization Practices has not issued guidance. Professional societies have been filling the gap.
For a 62-year-old trying to decide what to book, the practical answer is that the underlying medical reasoning remains unchanged. What has changed is where the recommendation comes from and how confidently a pharmacist can answer.
Aging Changes the Odds, Not Just the Discomfort
Immune function declines with age in ways that matter for exactly these infections. Antibody responses weaken, the pool of naive immune cells shrinks, and inflammation that runs at a low chronic level slows recovery.
The consequences show up as complications rather than as worse cold symptoms. Influenza and RSV in an older adult more often become pneumonia, and both can destabilize existing heart and lung disease. Hospitalization itself carries downstream risks in this age group, including deconditioning, delirium, and loss of independence that outlast the infection.
Pneumococcal bacteria cause pneumonia, bloodstream infection, and meningitis, and often follow a viral respiratory illness. Shingles is different in mechanism, a reactivation of the chickenpox virus that has been dormant since childhood, and the reason it surfaces later in life is the same waning immunity.
The Age Rules That Actually Apply
Influenza is the simplest. One dose every year for everyone aged 6 months and older. Adults 65 and over are directed toward the enhanced formulations, meaning high-dose, adjuvanted, or recombinant vaccines, which are designed for weaker immune responses.
RSV is the one most often misunderstood. It is recommended for all adults aged 75 and older, and for adults aged 50 through 74 who have risk factors such as chronic heart or lung disease, diabetes, kidney or liver disease, or who live in a nursing home. It is a single dose, not an annual dose.
Pneumococcal vaccination is recommended for adults 50 and older, and earlier for people with certain chronic conditions or weakened immune systems. Whether one or two doses are needed depends on which vaccines a person has already received, which is why records matter more here than for any other.
Shingles is two doses of the recombinant vaccine for adults 50 and older, and for adults 19 and older who are immunocompromised. Having had shingles already does not remove the recommendation, and neither does having had the older Zostavax vaccine years ago.
COVID-19 vaccination sits alongside these and follows its own timing. Updated flu and COVID vaccines are expected to be available with insurer coverage this season, as MedicalDaily reported in a piece on the gap left by the stalled advisory committee.
The Cost Picture and Where the Friction Sits
Medicare Part B covers influenza and pneumococcal vaccines with no cost sharing. Shingles and RSV vaccines fall under Part D, and since 2023, recommended adult vaccines under Part D have been available to beneficiaries without a deductible or copay.
That coverage has historically been tied to advisory committee recommendations, which is the mechanism now under strain. An insurance trade group said its member plans would keep covering every immunization the committee recommended as of September 1 of last year, with no cost sharing, through the end of this year. What happens after that is unresolved, and the pledge applies to member plans rather than to every insurer. Infectious disease specialists told CIDRAP News this month that updated flu and COVID vaccines will be available and that insurers have said they will cover them, at least for this season.
People without insurance face a harder path. Shingles and RSV vaccines are among the more expensive adult vaccines at retail. Local health departments, federally qualified health centers and some pharmacy chains offer reduced-cost options, and manufacturers run patient assistance programs worth asking about.
Timing is worth planning rather than improvising. Flu vaccination is generally recommended in September or October so protection holds through the peak. RSV, pneumococcal, and shingles are not seasonal and can be scheduled whenever convenient. Several can be given at the same visit, though some people prefer to space the doses apart because of a higher rate of arm soreness and short-lived flu-like symptoms.
Bringing the Right Information to the Appointment
The single most useful preparation is a list. Which vaccines, which year, and which product name, if available. Many pharmacies can pull their own records, and state immunization registries hold data for many adults, but gaps are common for anyone who has moved or changed providers.
Also bring a current medication list and a note of any condition affecting the immune system, including cancer treatment, transplant medication, biologics for autoimmune disease, or long-term steroids. Those change several of the recommendations above and are the most frequent reason a standard answer does not apply.
Reasonable expectations help. Arm soreness, fatigue, mild fever, and headache for a day or two are common and are not a reason to skip future doses. A pharmacist can administer most adult vaccines without a physician visit in most states, though the rules vary and the policy backdrop continues to shift, as MedicalDaily reported in coverage of a rewritten federal vaccine charter.
Anyone who is unsure should ask a clinician rather than working from a list in an article, including this one. Eligibility here turns on age, medical history, and prior doses, and no general guide can resolve an individual case.
One last note on framing. Coverage of adult vaccines often slides into presenting a fixed set of shots as a checklist everyone over a certain birthday must complete. That is not how any of these recommendations are written, and treating them that way tends to produce either unnecessary anxiety or blanket dismissal. The four discussed here are the ones most likely to come up in an appointment this season, which is a different claim from saying all four are owed.
Key Questions Answered
Do all four vaccines apply to everyone over 60? No. Flu is annual for everyone. RSV depends on age and risk factors. Pneumococcal starts at 50, with dose counts depending on history. Shingles is two doses from 50.
Who should get the RSV vaccine? All adults 75 and older, and adults 50 through 74 with risk factors such as chronic heart or lung disease, diabetes, kidney or liver disease, or nursing home residence. It is a single dose.
Why does the federal schedule still say 2025? The CDC adult schedule lists a July 2025 review date because the federal advisory committee has not issued any new guidance. Professional societies have continued to publish recommendations.
Does Medicare cover these? Part B covers flu and pneumococcal with no cost sharing. Shingles and RSV fall under Part D, where recommended adult vaccines have been available without deductible or copay since 2023.
Do I still need the shingles vaccine if I already had shingles? Yes, the recommendation still applies. It also applies to people who received the older Zostavax vaccine years ago.
When should I get the flu shot? Generally September or October, so protection holds through the peak of the season. The other three are not seasonal and can be scheduled any time.
What should I bring to the appointment? A list of prior vaccines with years and product names where possible, a current medication list, and a note of any condition or treatment affecting the immune system.
